Abstract

Background

The Editorial Board of EJNMMI Radiopharmacy and Chemistry releases a biannual highlight commentary to update the readership on trends in the field of radiopharmaceutical development.

Main Body

This selection of highlights provides commentary on 21 different topics selected by each coauthoring Editorial Board member addressing a variety of aspects ranging from novel radiochemistry to first-in-human application of novel radiopharmaceuticals.

Conclusion

Trends in radiochemistry and radiopharmacy are highlighted. Hot topics cover the entire scope of EJNMMI Radiopharmacy and Chemistry, demonstrating the progress in the research field, and include new PET-labelling methods for 11C and 18F, the importance of choosing the proper chelator for a given radioactive metal ion, implications of total body PET on use of radiopharmaceuticals, legislation issues and radionuclide therapy including the emerging role of 161Tb.

Details

Title
Highlight selection of radiochemistry and radiopharmacy developments by editorial board
Author
Kiss, Oliver C. 1   VIAFID ORCID Logo  ; Scott, Peter J. H. 2 ; Behe, Martin 3 ; Penuelas, Ivan 4 ; Passchier, Jan 5 ; Rey, Ana 6 ; Patt, Marianne 7 ; Aime, Silvio 8 ; Jalilian, Amir 9 ; Laverman, Peter 10 ; Cheng, Zhen 11 ; Chauvet, Alain Faivre 12 ; Engle, Jonathan 13 ; Cleeren, Frederik 14 ; Zhu, Hua 15 ; Vercouillie, Johnny 16 ; van Dam, Michael 17 ; Zhang, Ming Rong 18 ; Perk, Lars 10 ; Guillet, Benjamin 19 ; Alves, Francisco 20 

1  Helmholtz Zentrum Dresden Rossendorf, Dresden, Germany (GRID:grid.40602.30) (ISNI:0000 0001 2158 0612) 
2  University of Michigan, Ann Arbor, USA (GRID:grid.214458.e) (ISNI:0000000086837370) 
3  Paul Scherrer Institute, Villigen, Switzerland (GRID:grid.5991.4) (ISNI:0000 0001 1090 7501) 
4  University Clinic of Navarra, Pamplona, Spain (GRID:grid.411730.0) (ISNI:0000 0001 2191 685X) 
5  Invicro, Imperial College London, London, UK (GRID:grid.7445.2) (ISNI:0000 0001 2113 8111) 
6  Universidad de la Rebublica, Montevideo, Uruguay (GRID:grid.7445.2) 
7  University of Leipzig, Leipzig, Germany (GRID:grid.9647.c) (ISNI:0000 0004 7669 9786) 
8  University of Torino, Turin, Italy (GRID:grid.7605.4) (ISNI:0000 0001 2336 6580) 
9  IAEA, Vienna, Austria (GRID:grid.420221.7) (ISNI:0000 0004 0403 8399) 
10  Radboud University Medical Center, Nijmegen, The Netherlands (GRID:grid.10417.33) (ISNI:0000 0004 0444 9382) 
11  Shanghai Institute of Materia Medica, Shanghai, China (GRID:grid.419093.6) (ISNI:0000 0004 0619 8396) 
12  Inserm, Nantes, France (GRID:grid.457374.6) 
13  University of Wisconsin, Madison, USA (GRID:grid.28803.31) (ISNI:0000 0001 0701 8607) 
14  Katholieke Universiteit, Leuven, Belgium (GRID:grid.5596.f) (ISNI:0000 0001 0668 7884) 
15  Peking University Cancer Hospital, Beijing, China (GRID:grid.412474.0) (ISNI:0000 0001 0027 0586) 
16  University of Tours, Tours, France (GRID:grid.12366.30) (ISNI:0000 0001 2182 6141) 
17  UCLA, Los Angeles, USA (GRID:grid.19006.3e) (ISNI:0000 0000 9632 6718) 
18  NIRS, Chiba, Japan (GRID:grid.482503.8) (ISNI:0000 0004 5900 003X) 
19  CERIMED, Marseille, France (GRID:grid.10417.33) 
20  University of Coimbra, Coimbra, Portugal (GRID:grid.8051.c) (ISNI:0000 0000 9511 4342) 
Pages
6
Publication year
2023
Publication date
Dec 2023
Publisher
Springer Nature B.V.
e-ISSN
2365-421X
Source type
Scholarly Journal
Language of publication
English
DOI
https://doi.org/10.1186/s41181-023-00192-5
ProQuest document ID
2789893486
Copyright
© The Author(s) 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.